Advancements in genetic and molecular profiling allowed several abnormalities located in the phosphatidylinositol-4,5-bisphosphate 3 kinase catalytic subunit alpha (PIK3CA) and neuroblastoma RAS viral oncogene homolog (NRAS) pathways to be identified in canine sarcomas. The gene discussed is NRAS; the disease is sarcoma.